Business & Finance
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
16 October 2024 - Biopharmaceutical company Merck (NYSE: MRK), also known as MSD outside the US and Canada, has announced positive results from the STRIDE-8 Phase 3 trial for CAPVAXIVE (Pneumococcal 2...
Labcorp announces cash dividend
11 October 2024 - US clinical laboratory company Labcorp (NYSE: LH) announced on Thursday that it will pay a cash dividend of USD0.72 per share of common stock.This is unchanged from the previous quar...
Gilead expands global access to lenacapavir for HIV prevention
2 October 2024 - HIV medication company Gilead Sciences Inc (Nasdaq: GILD) announced on Wednesday that it has signed royalty-free voluntary licensing agreements with six generic manufacturers to incre...
Bruker acquires Dynamic Biosensors
2 October 2024 - Life science research and diagnostics solutions provider Bruker Corporation (Nasdaq:BRKR) announced on Wednesday that it has acquired biosensor development specialist Dynamic Biosenso...
Abbott announces quarterly common stock dividend
20 September 2024 - US-based global healthcare company Abbott (NYSE: ABT) announced on Thursday a quarterly common stock dividend of USD0.55 per share.This is unchanged from the previous quarter.The c...
Genomma Lab announces cash dividend
11 September 2024 - Genomma Lab Internacional, SAB de CV (BMV:LABB), a pharmaceutical and personal care products company in Latin America, announced on Tuesday that it has filed a Notice of Rights wit...